We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Diabetes Drugs To Feature Black Box Warning

Law360 (August 15, 2007, 12:00 AM EDT) -- Just days after deciding not to pull GlaxoSmithKline PLC's Avandia Type 2 diabetes drug from the shelves, the U.S. Food and Drug Administration has instead gotten the company and other manufacturers of antidiabetic medications to update their labels to reflect the risks of heart failure.

GSK and Takeda Pharmaceutical Co., the makers of Avandia, Actos, Avandaryl, Avandamet and Duetact—all drugs that help control blood sugar in adults with type 2 diabetes—agreed on Tuesday to update their boxes with the FDA's strongest form of a warning....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.